aluates Reports

$ 0.0

Automative

Global Haemophilus b Conjugate Vaccine (Hib) Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-24N7718

Global Haemophilus b Conjugate Vaccine Hib Market Insights and Forecast to 2028

BUY CHAPTERS

Global Haemophilus b Conjugate Vaccine (Hib) Market Research Report 2025

Code: QYRE-Auto-24N7718

Report

July 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi Pasteur SA.

GSK

Merck

Haemophilus b Conjugate Vaccine (Hib) Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Haemophilus b Conjugate Vaccine (Hib) Market

The global market for Haemophilus b Conjugate Vaccine (Hib) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Haemophilus b Conjugate Vaccine (Hib), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Haemophilus b Conjugate Vaccine (Hib).

The Haemophilus b Conjugate Vaccine (Hib) market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Haemophilus b Conjugate Vaccine (Hib) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Haemophilus b Conjugate Vaccine (Hib) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Haemophilus b Conjugate Vaccine (Hib) Market Report

Report Metric	Details
Report Name	Haemophilus b Conjugate Vaccine (Hib) Market
CAGR	5%
Segment by Type	Inactivated Vaccine Live Attenuated Vaccine
Segment by Application	Government Institution Private Sector Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi Pasteur, SA, GSK, Merck
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Haemophilus b Conjugate Vaccine (Hib) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Haemophilus b Conjugate Vaccine (Hib) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Haemophilus b Conjugate Vaccine (Hib) Market report?

Ans: The main players in the Haemophilus b Conjugate Vaccine (Hib) Market are Sanofi Pasteur, SA, GSK, Merck

What are the Application segmentation covered in the Haemophilus b Conjugate Vaccine (Hib) Market report?

Ans: The Applications covered in the Haemophilus b Conjugate Vaccine (Hib) Market report are Government Institution, Private Sector, Other

What are the Type segmentation covered in the Haemophilus b Conjugate Vaccine (Hib) Market report?

Ans: The Types covered in the Haemophilus b Conjugate Vaccine (Hib) Market report are Inactivated Vaccine, Live Attenuated Vaccine

Recommended Reports

Vaccine Types

Vaccine Equipment

Vaccine Adjacent Markets

1 Haemophilus b Conjugate Vaccine (Hib) Market Overview

1.1 Product Definition

1.2 Haemophilus b Conjugate Vaccine (Hib) by Type

1.2.1 Global Haemophilus b Conjugate Vaccine (Hib) Market Value Comparison by Type (2024 VS 2031)

1.2.2 Inactivated Vaccine

1.2.3 Live Attenuated Vaccine

1.3 Haemophilus b Conjugate Vaccine (Hib) by Application

1.3.1 Global Haemophilus b Conjugate Vaccine (Hib) Market Value by Application (2024 VS 2031)

1.3.2 Government Institution

1.3.3 Private Sector

1.3.4 Other

1.4 Global Haemophilus b Conjugate Vaccine (Hib) Market Size Estimates and Forecasts

1.4.1 Global Haemophilus b Conjugate Vaccine (Hib) Revenue 2020-2031

1.4.2 Global Haemophilus b Conjugate Vaccine (Hib) Sales 2020-2031

1.4.3 Global Haemophilus b Conjugate Vaccine (Hib) Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Haemophilus b Conjugate Vaccine (Hib) Market Competition by Manufacturers

2.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Manufacturers (2020-2025)

2.2 Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Haemophilus b Conjugate Vaccine (Hib) Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Haemophilus b Conjugate Vaccine (Hib), Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Haemophilus b Conjugate Vaccine (Hib), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Haemophilus b Conjugate Vaccine (Hib), Product Type & Application

2.7 Global Key Manufacturers of Haemophilus b Conjugate Vaccine (Hib), Date of Enter into This Industry

2.8 Global Haemophilus b Conjugate Vaccine (Hib) Market Competitive Situation and Trends

2.8.1 Global Haemophilus b Conjugate Vaccine (Hib) Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Haemophilus b Conjugate Vaccine (Hib) Players Market Share by Revenue

2.8.3 Global Haemophilus b Conjugate Vaccine (Hib) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Haemophilus b Conjugate Vaccine (Hib) Market Scenario by Region

3.1 Global Haemophilus b Conjugate Vaccine (Hib) Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Haemophilus b Conjugate Vaccine (Hib) Sales by Region: 2020-2031

3.2.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales by Region: 2020-2025

3.2.2 Global Haemophilus b Conjugate Vaccine (Hib) Sales by Region: 2026-2031

3.3 Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Region: 2020-2031

3.3.1 Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Region: 2020-2025

3.3.2 Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Region: 2026-2031

3.4 North America Haemophilus b Conjugate Vaccine (Hib) Market Facts & Figures by Country

3.4.1 North America Haemophilus b Conjugate Vaccine (Hib) Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2020-2031)

3.4.3 North America Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Haemophilus b Conjugate Vaccine (Hib) Market Facts & Figures by Country

3.5.1 Europe Haemophilus b Conjugate Vaccine (Hib) Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2020-2031)

3.5.3 Europe Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Market Facts & Figures by Region

3.6.1 Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Sales by Region (2020-2031)

3.6.3 Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Haemophilus b Conjugate Vaccine (Hib) Market Facts & Figures by Country

3.7.1 Latin America Haemophilus b Conjugate Vaccine (Hib) Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2020-2031)

3.7.3 Latin America Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Market Facts & Figures by Country

3.8.1 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2020-2031)

3.8.3 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2020-2031)

4.1.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2020-2025)

4.1.2 Global Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2026-2031)

4.1.3 Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Type (2020-2031)

4.2 Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Type (2020-2031)

4.2.1 Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Type (2020-2025)

4.2.2 Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Type (2026-2031)

4.2.3 Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Type (2020-2031)

4.3 Global Haemophilus b Conjugate Vaccine (Hib) Price by Type (2020-2031)

5 Segment by Application

5.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2020-2031)

5.1.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2020-2025)

5.1.2 Global Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2026-2031)

5.1.3 Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Application (2020-2031)

5.2 Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Application (2020-2031)

5.2.1 Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Application (2020-2025)

5.2.2 Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Application (2026-2031)

5.2.3 Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Application (2020-2031)

5.3 Global Haemophilus b Conjugate Vaccine (Hib) Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Sanofi Pasteur, SA

6.1.1 Sanofi Pasteur, SA Company Information

6.1.2 Sanofi Pasteur, SA Description and Business Overview

6.1.3 Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Product Portfolio

6.1.5 Sanofi Pasteur, SA Recent Developments/Updates

6.2 GSK

6.2.1 GSK Company Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Haemophilus b Conjugate Vaccine (Hib) Sales, Revenue and Gross Margin (2020-2025)

6.2.4 GSK Haemophilus b Conjugate Vaccine (Hib) Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Merck

6.3.1 Merck Company Information

6.3.2 Merck Description and Business Overview

6.3.3 Merck Haemophilus b Conjugate Vaccine (Hib) Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Merck Haemophilus b Conjugate Vaccine (Hib) Product Portfolio

6.3.5 Merck Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Haemophilus b Conjugate Vaccine (Hib) Industry Chain Analysis

7.2 Haemophilus b Conjugate Vaccine (Hib) Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Haemophilus b Conjugate Vaccine (Hib) Production Mode & Process Analysis

7.4 Haemophilus b Conjugate Vaccine (Hib) Sales and Marketing

7.4.1 Haemophilus b Conjugate Vaccine (Hib) Sales Channels

7.4.2 Haemophilus b Conjugate Vaccine (Hib) Distributors

7.5 Haemophilus b Conjugate Vaccine (Hib) Customer Analysis

8 Haemophilus b Conjugate Vaccine (Hib) Market Dynamics

8.1 Haemophilus b Conjugate Vaccine (Hib) Industry Trends

8.2 Haemophilus b Conjugate Vaccine (Hib) Market Drivers

8.3 Haemophilus b Conjugate Vaccine (Hib) Market Challenges

8.4 Haemophilus b Conjugate Vaccine (Hib) Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sanofi Pasteur SA.

GSK

Merck

List of Tables

Table 1. Global Haemophilus b Conjugate Vaccine (Hib) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Haemophilus b Conjugate Vaccine (Hib) Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Haemophilus b Conjugate Vaccine (Hib) Market Competitive Situation by Manufacturers in 2024

Table 4. Global Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses) of Key Manufacturers (2020-2025)

Table 5. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Haemophilus b Conjugate Vaccine (Hib) Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Haemophilus b Conjugate Vaccine (Hib) Average Price (US$/Dose) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Haemophilus b Conjugate Vaccine (Hib), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Haemophilus b Conjugate Vaccine (Hib), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Haemophilus b Conjugate Vaccine (Hib), Product Type & Application

Table 12. Global Key Manufacturers of Haemophilus b Conjugate Vaccine (Hib), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Haemophilus b Conjugate Vaccine (Hib) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilus b Conjugate Vaccine (Hib) as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Haemophilus b Conjugate Vaccine (Hib) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Region (2020-2025) & (K Doses)

Table 18. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Region (2020-2025)

Table 19. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Region (2026-2031) & (K Doses)

Table 20. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Region (2026-2031)

Table 21. Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Region (2020-2025)

Table 23. Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Region (2026-2031)

Table 25. North America Haemophilus b Conjugate Vaccine (Hib) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2020-2025) & (K Doses)

Table 27. North America Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2026-2031) & (K Doses)

Table 28. North America Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Haemophilus b Conjugate Vaccine (Hib) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2020-2025) & (K Doses)

Table 32. Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2026-2031) & (K Doses)

Table 33. Europe Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Sales by Region (2020-2025) & (K Doses)

Table 37. Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Sales by Region (2026-2031) & (K Doses)

Table 38. Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Haemophilus b Conjugate Vaccine (Hib) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2020-2025) & (K Doses)

Table 42. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2026-2031) & (K Doses)

Table 43. Latin America Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2020-2025) & (K Doses)

Table 47. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2026-2031) & (K Doses)

Table 48. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses) by Type (2020-2025)

Table 51. Global Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses) by Type (2026-2031)

Table 52. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Type (2020-2025)

Table 53. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Type (2026-2031)

Table 54. Global Haemophilus b Conjugate Vaccine (Hib) Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Haemophilus b Conjugate Vaccine (Hib) Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Type (2020-2025)

Table 57. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Type (2026-2031)

Table 58. Global Haemophilus b Conjugate Vaccine (Hib) Price (US$/Dose) by Type (2020-2025)

Table 59. Global Haemophilus b Conjugate Vaccine (Hib) Price (US$/Dose) by Type (2026-2031)

Table 60. Global Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses) by Application (2020-2025)

Table 61. Global Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses) by Application (2026-2031)

Table 62. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Application (2020-2025)

Table 63. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Application (2026-2031)

Table 64. Global Haemophilus b Conjugate Vaccine (Hib) Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Haemophilus b Conjugate Vaccine (Hib) Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Application (2020-2025)

Table 67. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Application (2026-2031)

Table 68. Global Haemophilus b Conjugate Vaccine (Hib) Price (US$/Dose) by Application (2020-2025)

Table 69. Global Haemophilus b Conjugate Vaccine (Hib) Price (US$/Dose) by Application (2026-2031)

Table 70. Sanofi Pasteur, SA Company Information

Table 71. Sanofi Pasteur, SA Description and Business Overview

Table 72. Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 73. Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Product

Table 74. Sanofi Pasteur, SA Recent Developments/Updates

Table 75. GSK Company Information

Table 76. GSK Description and Business Overview

Table 77. GSK Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 78. GSK Haemophilus b Conjugate Vaccine (Hib) Product

Table 79. GSK Recent Developments/Updates

Table 80. Merck Company Information

Table 81. Merck Description and Business Overview

Table 82. Merck Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 83. Merck Haemophilus b Conjugate Vaccine (Hib) Product

Table 84. Merck Recent Developments/Updates

Table 85. Key Raw Materials Lists

Table 86. Raw Materials Key Suppliers Lists

Table 87. Haemophilus b Conjugate Vaccine (Hib) Distributors List

Table 88. Haemophilus b Conjugate Vaccine (Hib) Customers List

Table 89. Haemophilus b Conjugate Vaccine (Hib) Market Trends

Table 90. Haemophilus b Conjugate Vaccine (Hib) Market Drivers

Table 91. Haemophilus b Conjugate Vaccine (Hib) Market Challenges

Table 92. Haemophilus b Conjugate Vaccine (Hib) Market Restraints

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Product Picture of Haemophilus b Conjugate Vaccine (Hib)

Figure 2. Global Haemophilus b Conjugate Vaccine (Hib) Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Haemophilus b Conjugate Vaccine (Hib) Market Share by Type: 2024 & 2031

Figure 4. Inactivated Vaccine Product Picture

Figure 5. Live Attenuated Vaccine Product Picture

Figure 6. Global Haemophilus b Conjugate Vaccine (Hib) Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Haemophilus b Conjugate Vaccine (Hib) Market Share by Application: 2024 & 2031

Figure 8. Government Institution

Figure 9. Private Sector

Figure 10. Other

Figure 11. Global Haemophilus b Conjugate Vaccine (Hib) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Haemophilus b Conjugate Vaccine (Hib) Market Size (2020-2031) & (US$ Million)

Figure 13. Global Haemophilus b Conjugate Vaccine (Hib) Sales (2020-2031) & (K Doses)

Figure 14. Global Haemophilus b Conjugate Vaccine (Hib) Average Price (US$/Dose) & (2020-2031)

Figure 15. Haemophilus b Conjugate Vaccine (Hib) Report Years Considered

Figure 16. Haemophilus b Conjugate Vaccine (Hib) Sales Share by Manufacturers in 2024

Figure 17. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Haemophilus b Conjugate Vaccine (Hib) Players: Market Share by Revenue in Haemophilus b Conjugate Vaccine (Hib) in 2024

Figure 19. Haemophilus b Conjugate Vaccine (Hib) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Haemophilus b Conjugate Vaccine (Hib) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country (2020-2031)

Figure 22. North America Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country (2020-2031)

Figure 26. Europe Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country (2020-2031)

Figure 27. Germany Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Region (2020-2031)

Figure 34. China Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Taiwan Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Philippines Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country (2020-2031)

Figure 45. Latin America Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Haemophilus b Conjugate Vaccine (Hib) by Type (2020-2031)

Figure 55. Global Revenue Market Share of Haemophilus b Conjugate Vaccine (Hib) by Type (2020-2031)

Figure 56. Global Haemophilus b Conjugate Vaccine (Hib) Price (US$/Dose) by Type (2020-2031)

Figure 57. Global Sales Market Share of Haemophilus b Conjugate Vaccine (Hib) by Application (2020-2031)

Figure 58. Global Revenue Market Share of Haemophilus b Conjugate Vaccine (Hib) by Application (2020-2031)

Figure 59. Global Haemophilus b Conjugate Vaccine (Hib) Price (US$/Dose) by Application (2020-2031)

Figure 60. Haemophilus b Conjugate Vaccine (Hib) Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Haemophilus Influenzae Type B Injection Vaccine Market Research Report 2025

Human Bacterial Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Haemophilia Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Haemophilus Influenzae Type B Vaccine Market Insights Forecast to 2030

Preventable Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibody Drug Conjugate Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Bottle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Ampoules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Administration Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Bordetella Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Therapeutic BCG Vaccines Market Insights Forecast to 2030

Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Aluminum based Vaccine Adjuvant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Plant based Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hemoglobinopathy Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccines Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Clostridium Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions